Does C-reactive protein modulate T-lymphocyte function in methotrexate-treated rheumatoid arthritis patients?
- PMID: 1364169
Does C-reactive protein modulate T-lymphocyte function in methotrexate-treated rheumatoid arthritis patients?
Abstract
Thirty-four patients with rheumatoid arthritis were treated with oral methotrexate for 6 months. Methotrexate was given as a single weekly dose of 7.5-10 mg. A correlation between serum concentration of CRP and proportion of CD8+ lymphocytes in peripheral blood was found in this group of patients. This correlation can be described by a linear regression equation. According to the results obtained, CRP suppresses lymphocyte function in patients with RA. This is the consequence of the stimulating effect on suppressor mechanisms.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous